V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270009549 | 270005664 | 1.73 | 71.4 | Curative (C) | 2017-12-24 | 2018-01-25 | Cetuximab + Radiotherapy Load | 02 | N | 270019236 | CARBOPLATIN |
| 270009550 | 270005665 | 1.74 | 72.8 | Neo-adjuvant (N) | 2015-08-04 | 2015-08-22 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270019244 | CARBOPLATIN |
| 270009551 | 270005665 | 1.75 | 97 | Adjuvant (A) | 2017-06-05 | 2017-06-08 | Carbo F | 2 | N | 270019244 | CARBOPLATIN + RT |
| 270009552 | 270005665 | 1.6 | 71.9 | Palliative (P) | 2016-06-01 | 2016-06-08 | Oxaliplatin + Raltitrexed | N | N | 270019244 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009553 | 270005665 | 1.59 | 78.3 | Curative (C) | 2017-04-14 | 2017-05-10 | CARBOPLATIN | N | N | 270019244 | CAPECITABINE + IRINOTECAN |
| 270009554 | 270005665 | 1.52 | 67.7 | Curative (C) | 2015-09-24 | 2015-09-29 | R ABVD | 02 | N | 270019244 | MITOMYCIN INTRAVESICULAR |
| 270009555 | 270019475 | 1.73 | 48.7 | null | 2017-10-30 | 2017-11-18 | Irinotecan | N | Y | 270019312 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270009556 | 270019815 | 1.73 | 71 | Palliative (P) | 2014-06-23 | 2014-06-23 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | Y | N | 270019316 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009557 | 270005666 | null | null | Palliative (P) | 2015-02-14 | 2015-02-14 | Capecitabine (14 day) + Irinotecan | N | N | 270019335 | CAPECITABINE + IRINOTECAN |
| 270009558 | 270005666 | 1.7 | 71 | Palliative (P) | 2015-03-24 | 2015-04-08 | Carboplatin AUC 6 - 10 | N | N | 270019335 | CARBO + FLUOROURACIL |
| 270009559 | 270005667 | 1.71 | 85 | Adjuvant (A) | 2013-08-07 | 2013-08-08 | Carboplatin AUC 6 - 10 | N | N | 270019349 | CETUXIMAB |
| 270009560 | 270005668 | null | 82 | null | 2015-08-14 | 2015-08-21 | Capecitabine + Cisplatin | N | N | 270019353 | BEVACIZUMAB + CAPECITABINE |
| 270009561 | 270005669 | 1.6 | 71.8 | Neo-adjuvant (N) | 2013-11-21 | 2014-04-01 | Bevacizumab + Cape + Oxali 21day | 02 | N | 270019367 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270009562 | 270005669 | null | 121.8 | Curative (C) | 2014-10-30 | 2014-11-12 | Irinotecan 14day | N | N | 270019367 | IRINOTECAN |
| 270009563 | 270005669 | 1.64 | 68 | Curative (C) | null | 2014-05-08 | FLUOROURACIL + MITOMYCIN + RT | N | N | 270019367 | CARBOPLATIN + RT |
| 270009564 | 270005670 | 1.7 | 71.1 | Palliative (P) | 2013-06-23 | 2013-07-08 | CARBOPLATIN + RT | 02 | N | 270019375 | CAPECITABINE + MITOMYCIN + RT |
| 270009565 | 270005671 | 1.71 | 85.2 | Palliative (P) | null | 2013-12-12 | FOXTROT TRIAL | N | N | 270019385 | CARBOPLATIN |
| 270009566 | 270005672 | null | null | null | 2014-07-12 | 2014-08-04 | GEMCITABINE | N | N | 270019403 | CETUXIMAB + RT |
| 270009567 | 270005672 | 1.57 | 72.5 | null | 2016-10-11 | 2016-10-12 | Brentuximab | 02 | Y | 270019403 | BRENTUXIMAB |
| 270009568 | 270005673 | 1.87 | 74.4 | Curative (C) | 2013-03-22 | 2013-03-25 | Enzalutamide | N | N | 270019416 | CETUXIMAB + RT |
| 270009569 | 270005673 | 1.76 | 112.8 | Curative (C) | 2013-02-22 | 2013-03-17 | Brentuximab | 02 | N | 270019416 | VINBLASTINE |
| 270009570 | 270005673 | 1.63 | 68.9 | Adjuvant (A) | 2014-07-27 | 2014-08-02 | Carboplatin AUC 2 - 5 | 02 | N | 270019416 | CETUXIMAB + RT |
| 270009571 | 270005674 | 1.8 | 78.6 | Neo-adjuvant (N) | 2016-07-12 | 2016-07-18 | Imatinib 400mg | N | N | 270019438 | CARBOPLATIN + RT |
| 270009572 | 270005675 | null | 82.3 | null | 2016-03-23 | 2016-03-23 | ECX | N | N | 270019441 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009573 | 270005675 | 1.85 | 66.9 | Palliative (P) | null | 2015-07-03 | IGEV | Y | N | 270019441 | LOPP |
| 270009574 | 270005675 | 1.76 | 87 | Neo-adjuvant (N) | 2015-08-20 | 2015-08-28 | CARBOPLATIN | 2 | N | 270019441 | CAPECITABINE + IRINOTECAN |
| 270009575 | 270005675 | 1.68 | null | null | 2017-04-21 | 2017-05-05 | Cetuximab 14 day | Y | null | 270019441 | CISPLATIN + VINORELBINE |
| 270009576 | 270005676 | 1.8 | 57.1 | Curative (C) | 2015-07-19 | 2015-07-26 | Cetuximab 7 day (>Cycle 2) | N | N | 270019453 | CARBOPLATIN + PEMETREXED |
| 270009577 | 270005677 | 1.78 | null | null | 2014-02-04 | 2014-02-04 | Cetuximab + Radiotherapy Load | null | null | 270019457 | GEMCARBO |
| 270009578 | 270005677 | 1.76 | 70.6 | Curative (C) | 2014-08-12 | 2014-09-01 | SCOT TRIAL | N | N | 270019457 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009579 | 270005678 | 1.77 | 82 | null | 2014-09-12 | 2014-09-29 | Carboplatin + Pemetrexed | null | null | 270019493 | ECF |
| 270009580 | 270005678 | 1.84 | 21.5 | Palliative (P) | null | 2016-07-29 | CAPECITABINE + IRINOTECAN | null | null | 270019493 | CETUXIMAB + IRINOTECAN + MDG |
| 270009581 | 270005678 | 1.81 | 71.1 | Palliative (P) | 2014-08-13 | 2014-08-13 | Fluorouracil + Folinic + RT Bossett | N | Y | 270019493 | CAPECITABINE + IRINOTECAN |
| 270009582 | 270017840 | 1.83 | 108.1 | Palliative (P) | 2016-11-18 | 2016-12-26 | FOXFIRE TRIAL | N | N | 270019520 | IRINOTECAN |
| 270009583 | 270005679 | 1.65 | 90 | Curative (C) | 2013-06-13 | 2013-06-22 | CETUXIMAB | 02 | N | 270019529 | NIVOLUMAB |
| 270009584 | 270005680 | 1.5 | 46 | Palliative (P) | 2017-02-13 | 2017-02-13 | CVP | N | null | 270019546 | NOT MATCHED |
| 270009585 | 270012804 | 1.52 | 82.3 | Palliative (P) | 2014-08-27 | 2014-08-27 | Bevacizumab 7.5mg/kg | N | N | 270019548 | CARBOPLATIN + ETOPOSIDE |
| 270009586 | 270012804 | 1.85 | 77.7 | null | 2016-08-04 | 2016-08-05 | Bevacizumab + Cape + Oxali 21day | Y | N | 270019548 | CETUXIMAB + OXALIPLATIN + MDG |
| 270009587 | 270005681 | null | 64.2 | Neo-adjuvant (N) | null | 2016-08-30 | CARBOPLATIN + RT | N | N | 270019562 | CARBO + FLUOROURACIL |
| 270009588 | 270005682 | 1.58 | 52.5 | Curative (C) | 2014-04-17 | 2014-04-17 | Cetuximab + Radiotherapy Load | 01 | N | 270019568 | FLUOROURACIL + RT |
| 270009589 | 270005683 | 1.55 | 63.2 | Palliative (P) | 2017-08-20 | 2017-09-15 | GEMCARBO | N | N | 270019571 | CARBOPLATIN + PEMETREXED |
| 270009590 | 270005683 | null | 79.5 | Neo-adjuvant (N) | null | 2013-10-24 | CETUXIMAB | N | N | 270019571 | CETUXIMAB + RT |
| 270009591 | 270016017 | 0 | 70.6 | Palliative (P) | 2013-08-01 | 2013-08-08 | IRINOTECAN + MDG + PANITUMUMAB | N | N | 270019599 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270009592 | 270016017 | 1.81 | 79 | Adjuvant (A) | 2016-07-24 | 2016-07-28 | Cetuximab + Radiotherapy Load | N | N | 270019599 | CARBOPLATIN + ETOPOSIDE |
| 270009593 | 270005684 | 1.71 | 71.4 | null | 2012-12-06 | 2014-07-16 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 270019601 | DOCETAXEL |
| 270009594 | 270005685 | 1.7 | 63.8 | null | 2017-05-19 | 2017-06-03 | FOXTROT TRIAL | N | N | 270019610 | CARBOPLATIN + PEMETREXED |
| 270009595 | 270012806 | 1.8 | 71.4 | null | 2015-10-16 | 2015-10-18 | Bevacizumab + Oxaliplatin +MdG | 2 | N | 270019620 | CARBOPLATIN + VINORELBINE |
| 270009596 | 270012806 | 1.6 | 61.6 | Adjuvant (A) | 2015-03-23 | 2015-03-30 | GemCarbo Days 1+8 | 02 | N | 270019620 | CARBOPLATIN |
| 270009597 | 270012806 | 1.83 | 117 | Palliative (P) | 2014-02-09 | 2014-02-19 | Capecitabine (14 day) + Irinotecan | 02 | N | 270019620 | BEVACIZUMAB + IRINOTECAN + MDG |
| 270009598 | 270018884 | null | 64 | null | 2013-07-18 | 2013-08-18 | null | N | N | 270019636 | CISPLATIN + FLUOROURACIL + RT |